| Literature DB >> 20047689 |
Monique M Cherrier1, Paul R Borghesani, Amy L Shelton, Celestia S Higano.
Abstract
BACKGROUND: A common treatment option for men with prostate cancer is androgen deprivation therapy (ADT). However, men undergoing ADT may experience physical side effects, changes in quality of life and sometimes psychiatric and cognitive side effects.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20047689 PMCID: PMC2824708 DOI: 10.1186/1471-2407-10-1
Source DB: PubMed Journal: BMC Cancer ISSN: 1471-2407 Impact factor: 4.430
SUMMARY OF STATISTICAL COMPARISONS
| Inputs | EVs in model | Output/contrasts | |
|---|---|---|---|
| ENCODE data | n.a. | ENCODE* data | |
| ICA data review (Separate for each paradigm and subject) | RECOG data | RECOG* data | |
| MATCH data | MATCH* data | ||
| ENCODE* data | EV1: route (or 3D) | C11 = EV1-EV2 | |
| Subject paradigm analysis (Separate for each paradigm and subject) | RECOG* data | EV2: survey (or 2D) | C12 = EV2-EV1 |
| MATCH* data | EV3: fixation | C13 = (EV1+EV2)-2*EV3 | |
| EV4-9: motion parameters of no interest | C14 = 2*EV3-(EV1+EV2) | ||
| C13 from each paradigm | EV1: time1 > time2 | C21 = EV1 | |
| Intra-subject analysis (Separate for each subject) | EV2-4: paired t-test parameters of no interest | C22 = -EV1 | |
| C21 from each subject | EV1: ADT | C31 = EV1 | |
| Group time1 vs. time2 analysis | EV2: CTR | C32 = -EV1 | |
| C33 = EV2 | |||
| C34 = -EV2 | |||
| C35 = EV1-EV2 | |||
| C36 = EV2-EV1 | |||
| C11 or C13 from each subject | EV1: ADTtime1 > ADTtime2 | C41 = EV1 | |
| Group paradigm analysis (Separate for each paradigm) | EV2: CTRtime1 > CTRtime2 | C42 = -EV1 | |
| EV3-14: paired t-test | C43 = EV2 | ||
| parameters of no interest | C44 = -EV2 | ||
| C45 = EV1-EV2 | |||
| C46 = EV2-EV1 | |||
| C13 from each subject | n.a. | n.a. | |
| Determining average z-scores (Separate for each paradigm and subject) |
Independent components analysis (ICA), explanatory variable (EV), contrast (C)
Figure 1Reduced left parietal activation in the ADT group at time. Four sections of a standardized brain with the area of reduced activation in the ADT group are shown (outlined by the green circle). No other areas of reduced activation were noted. See Methods and Table 2 for statistical details, p = 0.01 for cluster depicted.
ACTIVATION CHANGES IN THE RIGHT PARIETAL AREA BETWEEN BASELINE (TIME 1) & TREATMENT (TIME 2)
| Paradigm | Contrast | Brain region of cluster (all are right sided) | Cluster p-value | Area in cm3 | Z-max | Z-max MNI coordinates |
|---|---|---|---|---|---|---|
| All paradigms | ADTTime1 > ADTtime2 | precuneus, cuneus and lateral occipital lobe | 0.011 | 4.72 | 4.15 | 26,-62,40 |
| ENCODE | ADTtime1 > ADTtime2 | cuneus and lateral occipital lobe | 0.006 | 3.9 | 4.37 | 22,-88,-4 |
| precuneus | 0.028 | 2.15 | 4.71 | 26,-68,44 | ||
| CTRtime1 > CTRtime2 | precuneus, cuneus and lateral occipital lobe | 0.002 | 5.63 | 5.14 | 18,-72,46 | |
| RECOG | ADTtime1 > ADTtime2 | cuneus and precuneus | 0.001 | 6.74 | 4.88 | 26,-64,36 |
| ΔADT > ΔCTR | precuneus | 0.032 | 2.17 | 3.27 | 26,-64,36 | |
| MATCH | ADTtime1 > ADTtime2 | cuneus and precuneus | 0.002 | 6.26 | 5.67 | 34,-90,8 |
| ΔADT > ΔCTR | precuneus | 0.031 | 2.34 | 3.65 | 34,-82,32 |
Figure 2Reduced task-related activation in individual subjects during encoding, recognition and rotation at time. Task specific ROIs were defined by significant activation (over crosshair viewing) during the individual tasks in a mixed-effects GLM and the average Z-scores within these regions were determined for each subject (and for each task) at time1 and time2. For each subject, the difference in average z-scores was calculated (time2 - time1) and thus negative scores represent a decrease in task-related activation within an individual. Each point represents time2 - time1 from a single subject. See Table 2 for statistical details.